4//SEC Filing
Virsik Peter 4
Accession 0000950170-24-104661
CIK 0001633932other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 2:03 PM ET
Size
5.0 KB
Accession
0000950170-24-104661
Insider Transaction Report
Form 4
ESSA Pharma Inc.EPIX
Virsik Peter
Chief Operating Officer
Transactions
- Sale
Common Shares
2024-09-09$6.00/sh−694$4,164→ 8,470 total
Footnotes (2)
- [F1]The amount reflects the sale of shares pursuant to Mr. Virsik's 10b5-1 trading plan. The Rule 10b5-1 trading plan was entered into on August 31, 2023.
- [F2]The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Documents
Issuer
ESSA Pharma Inc.
CIK 0001633932
Entity typeother
Related Parties
1- filerCIK 0001826322
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 2:03 PM ET
- Size
- 5.0 KB